Mn(III) Porphyrin MnTE-2-PyP<sup>5+</sup> Associated with Ascorbate: A Redox-Active Therapeutic Strategy against Leishmaniasis. [PDF]
Souza THS +6 more
europepmc +1 more source
Setting the proportion of CD4+ and CD8+ T-cells co-cultured with canine macrophages infected with Leishmania chagasi. [PDF]
Viana KF +13 more
europepmc +1 more source
Similarity-Based Profiling of Hydrazone-Containing Scaffolds Active Against <i>Leishmania</i> Amastigotes. [PDF]
Pereira da Silva RY +5 more
europepmc +1 more source
Candidate antigens for serological testing (ELISA) and diagnosis of canine visceral leishmaniasis. [PDF]
Lira MGS +11 more
europepmc +1 more source
Identification of potent inhibitors of Leishmania donovani and Leishmania infantum chagasi, the causative agents of Old and New World visceral leishmaniasis. [PDF]
Zulfiqar B +8 more
europepmc +1 more source
The F1F3 recombinant chimera induced higher vaccine efficacy than its independent F1 and F3 components against <i>Leishmania</i> (<i>L.</i>) <i>infantum chagasi</i> mice infection. [PDF]
Gomes DC +3 more
europepmc +1 more source
Structure and Diversity of the Microbiome in Amazonian Sand Flies: Insights into Vector-Microbe Interactions. [PDF]
Caviedes-Triana K +5 more
europepmc +1 more source
From Abroad to Appalachia: A case report of cutaneous leishmaniasis in central Pennsylvania. [PDF]
Salmen N +4 more
europepmc +1 more source
Evaluation of 5 point-of-care tests for the detection of <i>Leishmania infantum</i> antibodies in dogs. [PDF]
Hailmann R +6 more
europepmc +1 more source
In vitro cytocidal effects of the essential oil from Croton cajucara (red sacaca) and its major constituent 7- hydroxycalamenene against Leishmania chagasi. [PDF]
ALVIANO, C. S. +8 more
core +1 more source

